Stock Traders Buy Large Volume of Call Options on Cooper Companies (NASDAQ:COO)

The Cooper Companies, Inc. (NASDAQ:COO) was the recipient of some unusual options trading on Monday. Stock investors bought 4,486 call options on the stock. This represents an increase of approximately 534% compared to the average daily volume of 708 call options.

Analysts Set New Price Targets

COO has been the subject of a number of research analyst reports. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Stifel Nicolaus lowered their price target on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Robert W. Baird cut their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. Finally, Wells Fargo & Company reiterated a “sell” rating and issued a $66.00 price target (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, Cooper Companies presently has an average rating of “Hold” and an average target price of $81.36.

Hedge Funds Weigh In On Cooper Companies

Institutional investors and hedge funds have recently modified their holdings of the business. Avalon Trust Co purchased a new position in Cooper Companies during the second quarter worth approximately $25,000. Root Financial Partners LLC increased its position in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after buying an additional 162 shares in the last quarter. SJS Investment Consulting Inc. increased its position in shares of Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after buying an additional 187 shares in the last quarter. Elevation Wealth Partners LLC raised its stake in shares of Cooper Companies by 1,136.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after buying an additional 375 shares during the period. Finally, J.Safra Asset Management Corp acquired a new position in shares of Cooper Companies during the 2nd quarter worth approximately $32,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Cooper Companies stock traded up $1.59 during mid-day trading on Monday, hitting $75.82. The company had a trading volume of 441,489 shares, compared to its average volume of 2,385,922. The company has a market capitalization of $14.79 billion, a price-to-earnings ratio of 64.14, a P/E/G ratio of 1.94 and a beta of 0.83. Cooper Companies has a 12-month low of $58.89 and a 12-month high of $89.83. The company’s fifty day moving average is $69.64 and its 200-day moving average is $71.44. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same period in the previous year, the business posted $0.96 EPS. The business’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts predict that Cooper Companies will post 4.63 EPS for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.